14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Jul 11, 2016 $17.69 $17.94 $17.38 $17.51 217 700
Jul 08, 2016 $17.21 $17.74 $17.08 $17.62 349 400
Jul 07, 2016 $16.65 $17.22 $16.52 $17.06 241 400
Jul 06, 2016 $16.48 $16.98 $16.07 $16.63 276 100
Jul 05, 2016 $17.24 $17.24 $16.33 $16.66 289 300
Jul 01, 2016 $16.42 $17.75 $16.42 $17.37 1 226 700
Jun 30, 2016 $15.96 $16.85 $15.80 $16.59 683 000
Jun 29, 2016 $16.02 $16.45 $15.64 $16.10 635 100
Jun 28, 2016 $14.99 $16.11 $14.95 $15.68 895 600
Jun 27, 2016 $15.64 $15.69 $14.22 $14.70 1 282 600
Jun 24, 2016 $15.99 $17.00 $15.62 $15.69 1 761 100
Jun 23, 2016 $17.68 $17.90 $16.50 $16.74 1 159 500
Jun 22, 2016 $17.71 $18.08 $16.81 $17.56 2 223 300
Jun 21, 2016 $19.89 $20.14 $17.42 $17.80 7 342 500
Jun 20, 2016 $17.61 $19.91 $17.60 $18.94 1 266 800
Jun 17, 2016 $19.00 $19.24 $17.76 $17.83 494 000
Jun 16, 2016 $19.41 $19.41 $17.83 $18.85 907 517
Jun 15, 2016 $20.60 $20.87 $19.24 $19.50 864 871
Jun 14, 2016 $21.83 $23.01 $21.04 $21.10 507 612
Jun 13, 2016 $23.50 $23.62 $21.10 $22.02 1 106 095
Jun 10, 2016 $24.72 $27.99 $22.76 $24.15 4 723 654
Jun 09, 2016 $23.99 $24.50 $22.02 $22.15 546 042
Jun 08, 2016 $24.56 $24.61 $23.16 $24.13 266 135
Jun 07, 2016 $25.62 $25.90 $24.30 $24.36 278 077
Jun 06, 2016 $25.96 $26.55 $25.28 $25.90 186 187
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT